![]() |
|||||||||||||||||||||||||
Research Interests: One of our groups long-term interests involves transcriptional regulation of the genes of the primate DNA tumor viruses simian virus 40 (SV40), hepatitis B virus (HBV) and Epstein-Barr virus (EBV) that have been implicated in a variety of human cancers. We have found that members of the steroid/thyroid/retinoid hormone receptor superfamily play direct roles in regulating transcription and replication of SV40 and HBV, indicating that appropriate analogues of ligands to these receptors may prove useful as anti-viral drugs for the treatment of acute and chronic infections by some viruses. Recently, we have identified new factors including ZEB1 (deltaEF1) and ZEB2 (SIP1), that play crucial roles in the establishment and maintenance of EBV latency and reactivation of EBV into replication. Understanding the activities of these factors and how they are altered via cell signaling pathways may lead to new therapies for treating some EBV-associated diseases including lymphomas and carcinomas. Our groups second area of research concerns the roles of the human estrogen-related receptor a(ERRa) in regulation of estrogen responsiveness and breast carcinogenesis. We have found that ERRa can function either as a down-modulator or a constitutive activator of estrogen response element-directed transcription, with its activity likely regulated in part by post-translational modifications occurring via ErbB2 signaling pathways. We have also determined that ERR_ is likely a major player in the subset of breast cancers lacking estrogen receptor activity or resistant to tamoxifen. Thus, understanding how ERR_s activities are affected by signaling pathways may lead to the development of additional tools for prognosis and therapeutic treatments, especially for ER-negative and tamoxifen-resistant breast cancers. Selected Recent Publications: Articles on PubMed
|